Entellus Medical (ENTL) Misses Q3 EPS by 13c

Entellus Medical (NASDAQ: ENTL) reported Q3 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.9 million versus the consensus estimate of $17.93 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $74.0-75.5 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• Brunswick (BC) Reports In-Line Q1 EPS, provides guidance
• Sanofi jumps as Q1 key profit measure tops estimates; Citi reiterates Buy
• Caterpillar (CAT) Tops Q1 EPS by 46c, Misses on Revenue